Everything you need to know about TMS for Older Adults: Addressing Depression in Aging Populations — how it works, what it costs, and how to find a provider who actually knows what they're doing.
Depression in older adults is a significant public health issue that receives insufficient attention. Approximately 15-20% of adults over 65 experience clinically significant depression, but the condition is frequently underdiagnosed, undertreated, or dismissed as a normal part of aging. It is not.
Late-life depression carries serious consequences: increased mortality from medical conditions, faster cognitive decline, higher suicide rates in certain subgroups, reduced functional independence, and diminished quality of life. Yet treatment rates remain low, partly because standard treatments present specific challenges in older populations.
TMS offers particular advantages for this group, and the evidence base supports its use in late-life depression.
Why Late-Life Depression Is Different
Depression in older adults has distinctive features:
Somatic symptom focus. Older adults with depression often present with physical complaints — fatigue, pain, insomnia — rather than classic mood symptoms. This can lead to misattribution of depression to other medical conditions.
Cognitive overlap. Memory and concentration difficulties in depression can overlap with early dementia. Treating depression improves cognition in many cases, but the diagnostic confusion leads some patients to not receive appropriate treatment.
Medical comorbidity. Older adults typically have more medical conditions than younger patients. Cardiovascular disease, stroke history, Parkinson’s disease, cancer, and chronic pain all affect both depression risk and treatment options.
Medication burden. Older adults are more likely to be taking multiple medications, increasing the risk of drug interactions with antidepressants. Polypharmacy is a genuine concern.
Cognitive impairment. Vascular changes, early dementia, and the cognitive effects of depression itself can make it difficult to engage with psychotherapeutic approaches.
Why Standard Treatments Are More Challenging in Older Adults
Medications in older adults: Antidepressants carry increased risks in older populations — falls, hyponatremia, cardiovascular effects, anticholinergic burden. The START/STOPP criteria specifically caution against certain antidepressants in older adults. Many older patients cannot tolerate standard medications, or cannot take them at therapeutic doses due to side effects.
Psychotherapy: Some older adults have difficulty engaging with cognitive-behavioral approaches due to cognitive changes. However, interpersonal therapy and other approaches are well-suited to the specific challenges of late-life depression (bereavement, role transitions, chronic illness adaptation).
ECT: Electroconvulsive therapy is the most effective treatment for severe depression in older adults and is often used for treatment-resistant cases. However, it requires anesthesia and carries risks of cognitive effects that are particularly concerning in patients with cognitive vulnerability.
TMS in Older Adults: The Evidence
The evidence for TMS in late-life depression is accumulating:
A 2020 meta-analysis in International Journal of Geriatric Psychiatry found that TMS was effective in older adults with depression, though response rates were somewhat lower than in younger populations (approximately 40-45% response vs. 50-55% in younger adults).
A 2021 study specifically in adults over 65 found that age did not significantly predict TMS response once medical factors were accounted for — suggesting that the apparent age effect in some studies may reflect the medical complexity of older populations rather than biological age-related changes in TMS response.
Neuroimaging studies have shown that TMS produces measurable plastic changes in the prefrontal cortex of older adults, though the magnitude of change may be somewhat reduced compared to younger adults.
Key factors that predict TMS response in older adults include:
- Baseline cognitive function (better function predicts better response)
- Medical comorbidity burden
- Duration of the current depressive episode
- Treatment resistance history
Practical Considerations for Older Adults
Medical evaluation. Older adults should have a thorough medical evaluation before TMS, including assessment of neurological status, cardiovascular health, and any conditions that might affect treatment. This is good practice at any age but particularly important in older populations.
Medication review. A full medication review is essential before TMS. Some medications (tricyclic antidepressants, some antipsychotics) lower the seizure threshold and may affect TMS parameters. Coordination between your TMS clinician and prescribing physician is important.
Cognitive monitoring. Cognitive function should be assessed before and during TMS treatment. If cognitive changes occur, distinguishing between depression-related improvement and medication or TMS effects is important.
Caregiver involvement. TMS requires daily clinic visits for weeks. For older adults with mobility limitations or without transportation, the logistics can be challenging. Caregiver support for transportation and logistics is often necessary.
Safety considerations. Fall risk, cardiovascular stability, and general physical health status should be factored into treatment planning. Reputable TMS programs have protocols for assessing and managing these factors.
Why TMS May Be Particularly Well-Suited for This Population
TMS offers several advantages specifically relevant to older adults:
Tolerability. The side effect profile of TMS — primarily mild headache and scalp discomfort — is far more manageable for older adults than the side effects of many antidepressants, which can include sedation, dizziness, falls, and cardiac effects.
No drug interactions. TMS does not interact with other medications. This is a significant advantage for patients on complex medication regimens.
Cognitive safety. Unlike some antidepressants and unlike ECT, TMS does not carry significant cognitive risks in older adults. In fact, TMS often improves cognitive function as depression improves.
Non-invasive. Older adults who are medically fragile or cannot tolerate anesthesia for ECT may find TMS to be the appropriate escalation from medication and therapy alone.
Rapid response. Some older adults improve within 2-3 weeks of TMS treatment, earlier than the typical response to medication adjustments. This can be significant for those with limited life expectancy or time horizons.
Access Considerations for Older Adults
Accessing TMS presents specific challenges for older adults:
Transportation. Daily clinic visits require reliable transportation. This is a major barrier for older adults who no longer drive.
Caregiver support. Successful TMS treatment in older adults often requires a caregiver who can provide transportation, support during sessions, and monitoring at home.
Insurance navigation. Medicare covers TMS for eligible beneficiaries, but prior authorization processes can be confusing. Family members often need to assist with this navigation.
Long wait times. Some TMS clinics have significant waitlists. Older adults in crisis may not be able to wait months for an appointment.
Addressing these barriers requires family and community support. If you have an older family member who could benefit from TMS, helping with logistics — transportation, insurance, scheduling — may be the most important form of support you can provide.
A Final Note
Late-life depression is not a normal part of aging. It is a medical condition that responds to treatment, including TMS. Older adults deserve access to effective, tolerable treatments, and they should not have to accept diminished quality of life due to depression.
The barriers to treatment in this population are real but often surmountable. With appropriate support, older adults can access TMS and benefit from it substantially.
The brain at any age retains some capacity for change. TMS helps older adults access that capacity.